As of May 2026

Coverage varies by plan. This information summarizes publicly-disclosed formulary information as of the date above. Always confirm with your insurer.

Does UnitedHealthcare Cover Ozempic, Wegovy, Mounjaro, and Zepbound?

UnitedHealthcare (UHC) uses OptumRx as its pharmacy benefit manager and covers Ozempic and Mounjaro for Type 2 diabetes on most commercial group plans. Coverage for Wegovy and Zepbound for weight loss is available on plans that include GLP-1 weight-management benefits — but whether your specific employer elected that coverage determines whether it applies to you. This page summarizes UHC's publicly available formulary and clinical prior authorization criteria as of May 2026.

Ozempic (semaglutide) — Type 2 Diabetes

Generally Covered
Coverage Status
Yes — for diabetes
Formulary Tier
Tier 2 or Tier 3
Prior Auth Required
Yes
Typical OOP (with coverage)
$60–$150/mo

UHC covers Ozempic for Type 2 diabetes on most commercial plans, placing it on Tier 2 or Tier 3 of the OptumRx formulary. Prior authorization requires a confirmed diabetes diagnosis and current A1C documentation; some plans also require step therapy with metformin. UHC does not require cardiovascular documentation for diabetes-indicated coverage — only a confirmed diagnosis. The standard copay range for Tier 2–3 specialty medications is $15–$60 per fill per UHC's published cost information, though your actual cost depends on your deductible and coinsurance. Ozempic is not covered when prescribed solely for weight loss. Novo Nordisk's NovoCare savings program may reduce costs to as low as $25/month for eligible commercially insured patients.

Wegovy (semaglutide) — Weight Management

Varies by Plan
Coverage Status
Employer-dependent
Formulary Tier
Tier 4–5 (specialty)
Prior Auth Required
Yes — always
Typical OOP (with coverage)
$100–$400/mo

For employer-sponsored commercial plans that include GLP-1 weight-management benefits, UHC may cover Wegovy with prior authorization. UHC's clinical pharmacy policy (per published UHC Provider PA criteria) requires: BMI of 30 or greater (or 27 or greater with a qualifying weight-related comorbidity), documentation of lifestyle modifications, and use alongside behavioral support. Initial authorization covers four months; 12-month renewals require documented weight loss of at least 5% from baseline. Weight-loss GLP-1s are placed on Tier 4 or Tier 5 (specialty) on most UHC formularies, which means higher copay or coinsurance amounts. Individual and marketplace UHC plans rarely cover Wegovy. State mandates in California, New Mexico, North Dakota, and New York may impose specific coverage requirements. Novo Nordisk's NovoCare savings program may reduce costs for eligible commercially insured patients. As of May 2026, Wegovy for cardiovascular risk reduction and MASH is listed as non-formulary on some UHC commercial plans per UHC's published pharmacy update.

Mounjaro (tirzepatide) — Type 2 Diabetes

Generally Covered
Coverage Status
Yes — for diabetes
Formulary Tier
Tier 2 or Tier 3
Prior Auth Required
Yes
Typical OOP (with coverage)
$60–$150/mo

UHC covers Mounjaro for Type 2 diabetes on most commercial plans, typically at Tier 2 or Tier 3 on the OptumRx formulary. Prior authorization requires a confirmed diabetes diagnosis through ICD-10 codes or A1C of 6.5% or greater; documentation of prior medication history is required. Notably, UHC's published clinical policy for GLP-1 diabetes coverage does not explicitly require BMI documentation — only diabetes confirmation. Authorization for diabetes indications is typically issued for 12 months. Mounjaro is not covered when prescribed off-label for weight loss. Eli Lilly's Lilly Savings Card may reduce costs to $25/month for eligible commercially insured patients.

Zepbound (tirzepatide) — Weight Management

Employer-Dependent
Coverage Status
If employer opts in
Formulary Tier
Specialty (Tier 4–5)
Prior Auth Required
Yes — always
Typical OOP (without coverage)
~$1,080/mo list price

For employer-sponsored plans that include GLP-1 weight-loss benefits, UHC can cover Zepbound with prior authorization. Key criteria include BMI of 30 or greater (or 27 or greater with a qualifying comorbidity), documentation of lifestyle modifications, and a step therapy trial of phentermine (or phentermine/topiramate). A notable distinction from some other carriers: UHC does not require a prior trial of Wegovy or Saxenda before approving Zepbound. Initial authorization under weight-loss criteria is typically issued for six months. UHC Medicaid in some states (including Massachusetts) covers Zepbound on preferred formularies. Individual and marketplace UHC plans rarely include Zepbound. Medicare Part D plans do not cover Zepbound for weight loss under current federal law. UHC's OptumRx automated prior authorization can process approvals in under 30 seconds for eligible cases per UHC's published PA process.

How to Check Your Specific UnitedHealthcare Plan

UHC formularies vary by plan, employer, and state. Whether GLP-1 weight-loss coverage exists depends on what your employer elected when designing your benefits package.

  1. Call the number on the back of your UHC insurance card and ask to speak with Pharmacy Benefits (OptumRx).
  2. Ask specifically: "Is [medication name] covered on my formulary for [Type 2 diabetes / weight management]?"
  3. Reference the NDC for the specific medication — Ozempic NDC: 0169-4060; Wegovy NDC: 0169-4550; Mounjaro NDC: 0002-1436; Zepbound NDC: 0002-1453.
  4. Ask: "Is prior authorization required, and what must my doctor document?"
  5. Ask: "Does my plan require step therapy before this medication is approved?"
  6. Log in to your UHC member portal at uhc.com to search the drug formulary under Pharmacy Coverage.

If UnitedHealthcare Does Not Cover Your Medication

If your UHC plan excludes Ozempic, Wegovy, Mounjaro, or Zepbound, or if your prior authorization is denied, these telehealth providers can prescribe GLP-1 medications and ship to your home.

Advertising disclosure: The telehealth options below are paid sponsors. We may earn a commission when you sign up. This does not affect your pricing. Listing order does not imply medical recommendation. Always consult a licensed healthcare provider.

Peter MDSponsored

Physician-led longevity and weight management. GLP-1 options including Ozempic, Wegovy, Mounjaro, and Zepbound.

- Physician-Led Program
- Ozempic / Wegovy Access
TMates GLP1Sponsored

Direct-to-patient GLP-1 with streamlined intake. Mounjaro and Zepbound available with home shipping.

- Mounjaro / Zepbound
- Home Shipping
Oak LongevitySponsored

Longevity-focused weight management with GLP-1 access including Wegovy and Zepbound programs.

- Wegovy / Zepbound
- Metabolic Care
Trim RxSponsored

Telehealth GLP-1 prescriptions with direct provider consultations. Ozempic and Mounjaro options available.

- Ozempic / Mounjaro
- Home Delivery
HersSponsored

Women's telehealth platform with GLP-1 weight management including Wegovy and Zepbound options.

- Wegovy / Zepbound
- Women's Health

Frequently Asked Questions — UnitedHealthcare GLP-1 Coverage

Does UnitedHealthcare cover Ozempic for weight loss?

No. UHC does not cover Ozempic when prescribed for weight loss. Ozempic is FDA-approved for Type 2 diabetes, and insurance coverage — including UHC's — is limited to that approved indication. Patients seeking semaglutide for weight loss should ask about Wegovy, which is FDA-approved for chronic weight management. Coverage for Wegovy depends on whether your employer's UHC plan includes GLP-1 weight-management benefits.

Does UnitedHealthcare require step therapy for GLP-1 medications?

For diabetes-indicated GLP-1s like Ozempic and Mounjaro, some UHC plans require step therapy — typically documentation of a prior metformin trial. For weight-loss GLP-1s like Wegovy and Zepbound, many UHC plans require a prior trial of phentermine or phentermine/topiramate. Notably, UHC does not require a prior trial of Wegovy or Saxenda before approving Zepbound, which distinguishes it from some other carriers.

What does UHC cover Wegovy for — weight loss, cardiovascular risk, or both?

UHC commercial group plans that include weight-management drug benefits cover Wegovy for obesity (BMI of 30 or greater) or overweight with qualifying comorbidities (BMI of 27 or greater). However, as of May 2026, Wegovy specifically for cardiovascular risk reduction and MASH is listed as non-formulary on some UHC commercial plans, per UHC's published pharmacy update. Patients with a cardiovascular indication should confirm their specific plan's rules with UHC directly.

What states have UnitedHealthcare GLP-1 coverage mandates?

California, New Mexico, North Dakota, and New York have state mandates that may require coverage of weight-loss medications like Wegovy and Zepbound in fully insured plans. UHC's published clinical prior authorization criteria acknowledge these state-specific requirements. Self-funded employer plans are generally exempt from state insurance mandates under federal ERISA law. If you are in one of these states, confirm with UHC whether your plan is fully insured or self-funded, as this affects whether the mandate applies.

How long does prior authorization take with UnitedHealthcare?

Standard PA review with UHC takes up to 15 business days. Expedited review — available when delay would seriously jeopardize health — is decided within 72 hours. OptumRx automated prior authorization can complete approvals in under 30 seconds for eligible cases when submitted electronically through the UHC Provider Portal. If denied, you have 12 months to file an internal reconsideration, with a decision within 10 business days. If the internal appeal is denied, you may seek external review through an Independent Review Organization (IRO) via your state's insurance commissioner.

Sources and references: UHC Weight Loss PA Criteria (PDF) · UHC Pharmacy Update May 2026 (PDF) · UHC Diabetes GLP-1 PA Criteria (PDF) · NovoCare Savings (novocare.com) · Lilly Savings Card (lillydirect.com) · SingleCare UHC/Ozempic Analysis